Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-033063
Filing Date
2023-09-19
Accepted
2023-09-19 16:05:22
Documents
1
Period of Report
2023-09-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3913
  Complete submission text file 0001493152-23-033063.txt   5210
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Issuer) CIK: 0001614067 (see all company filings)

EIN.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5941 OPTICAL CT. SAN JOSE CA 95138
Business Address
Truong Vu (Reporting) CIK: 0001749993 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38630 | Film No.: 231263721